4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Embecta Corp. (EMBC) operates in the Medical Instruments & Supplies industry and is headquartered in Parsippany, United States with about 1,850 employees. Its market capitalization is roughly $380 million. In the fiscal year ended 2025-09-30, EMBC reported $1.1B in revenue and $95M in net income.
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally.
Interactive charts & full statements → Open the EMBC valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Total Revenue | $1.0B | $1.1B | $1.1B | $1.1B | $1.1B |
| Gross Profit | $601M | $677M | $735M | $750M | $775M |
| Operating Income (EBIT) | $224M | $242M | $167M | $222M | $310M |
| Net Income | $88M | $95M | $78M | $70M | $224M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $272M | $222M | $261M | $264M | $296M | — |
| Gross Profit | $153M | $128M | $162M | $158M | $197M | — |
| Operating Income (EBIT) | $49M | $35M | $83M | $56M | $94M | — |
| Net Income | $21M | ($4M) | $44M | $26M | $46M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Dividends Paid | ($27M) | ($35M) | ($34M) | ($34M) | ($9M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | ($1M) | ($9M) | ($9M) | ($9M) | ($9M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Total Assets | $1.1B | $1.3B | $1.2B | $1.1B |
| Total Liabilities | $1.7B | $2.0B | $2.0B | $2.0B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EMBC viewer.
About TickerBase · Data methodology & sources · Privacy · Terms